231 related articles for article (PubMed ID: 31603951)
1. Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG.
Kumova OK; Fike AJ; Thayer JL; Nguyen LT; Mell JC; Pascasio J; Stairiker C; Leon LG; Katsikis PD; Carey AJ
PLoS Pathog; 2019 Oct; 15(10):e1008072. PubMed ID: 31603951
[TBL] [Abstract][Full Text] [Related]
2. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses.
Harata G; He F; Hiruta N; Kawase M; Kubota A; Hiramatsu M; Yausi H
Lett Appl Microbiol; 2010 Jun; 50(6):597-602. PubMed ID: 20438620
[TBL] [Abstract][Full Text] [Related]
3. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage.
Zelaya H; Tada A; Vizoso-Pinto MG; Salva S; Kanmani P; Agüero G; Alvarez S; Kitazawa H; Villena J
Inflamm Res; 2015 Aug; 64(8):589-602. PubMed ID: 26072063
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection.
Kawase M; He F; Kubota A; Harata G; Hiramatsu M
Lett Appl Microbiol; 2010 Jul; 51(1):6-10. PubMed ID: 20438618
[TBL] [Abstract][Full Text] [Related]
5. Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways.
Buczynski BW; Yee M; Martin KC; Lawrence BP; O'Reilly MA
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L282-90. PubMed ID: 23748535
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
7. Influenza-Mediated Lung Infection Models.
McGee CE; Sample CJ; Kilburg-Basnyat B; Gabor KA; Fessler MB; Gowdy KM
Methods Mol Biol; 2019; 1960():191-205. PubMed ID: 30798533
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of Duox2 DNA using cationic polymer can prevent acute influenza A viral infection in vivo lung.
Kim BJ; Cho SW; Jeon YJ; An S; Jo A; Lim JH; Kim DY; Won TB; Han DH; Rhee CS; Kim HJ
Appl Microbiol Biotechnol; 2018 Jan; 102(1):105-115. PubMed ID: 28936773
[TBL] [Abstract][Full Text] [Related]
10. Heat-killed Lactobacillus gasseri TMC0356 protects mice against influenza virus infection by stimulating gut and respiratory immune responses.
Kawase M; He F; Kubota A; Yoda K; Miyazawa K; Hiramatsu M
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):280-8. PubMed ID: 22098223
[TBL] [Abstract][Full Text] [Related]
11. The role of interferon in influenza virus tissue tropism.
García-Sastre A; Durbin RK; Zheng H; Palese P; Gertner R; Levy DE; Durbin JE
J Virol; 1998 Nov; 72(11):8550-8. PubMed ID: 9765393
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.
Rajesh Kumar S; Syed Khader SM; Kiener TK; Szyporta M; Kwang J
PLoS One; 2013; 8(6):e63856. PubMed ID: 23762234
[TBL] [Abstract][Full Text] [Related]
13. Oral intake of Lactobacillus rhamnosus M21 enhances the survival rate of mice lethally infected with influenza virus.
Song JA; Kim HJ; Hong SK; Lee DH; Lee SW; Song CS; Kim KT; Choi IS; Lee JB; Park SY
J Microbiol Immunol Infect; 2016 Feb; 49(1):16-23. PubMed ID: 25304268
[TBL] [Abstract][Full Text] [Related]
14. Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection.
Lee GI; Saravia J; You D; Shrestha B; Jaligama S; Hebert VY; Dugas TR; Cormier SA
Part Fibre Toxicol; 2014 Oct; 11():57. PubMed ID: 25358535
[TBL] [Abstract][Full Text] [Related]
15. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
[TBL] [Abstract][Full Text] [Related]
16. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
[TBL] [Abstract][Full Text] [Related]
17. Protective Intranasal Immunization Against Influenza Virus in Infant Mice Is Dependent on IL-6.
Bonney EA; Krebs K; Kim J; Prakash K; Torrance BL; Haynes L; Rincon M
Front Immunol; 2020; 11():568978. PubMed ID: 33193346
[TBL] [Abstract][Full Text] [Related]
18. Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.
Van Leuven JT; Gonzalez AJ; Ijezie EC; Wixom AQ; Clary JL; Naranjo MN; Ridenhour BJ; Miller CR; Miura TA
mSphere; 2021 Jun; 6(3):e0047921. PubMed ID: 34160242
[TBL] [Abstract][Full Text] [Related]
19. Intratracheal administration of influenza virus is superior to intranasal administration as a model of acute lung injury.
Morales-Nebreda L; Chi M; Lecuona E; Chandel NS; Dada LA; Ridge K; Soberanes S; Nigdelioglu R; Sznajder JI; Mutlu GM; Budinger GR; Radigan KA
J Virol Methods; 2014 Dec; 209():116-20. PubMed ID: 25239366
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice.
Maeda N; Nakamura R; Hirose Y; Murosaki S; Yamamoto Y; Kase T; Yoshikai Y
Int Immunopharmacol; 2009 Aug; 9(9):1122-5. PubMed ID: 19410659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
